Business Description
Rapid Dose Therapeutics Corp
NAICS : 325412
SIC : 3741
ISIN : CA0047731074
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -2.28 | |||||
Debt-to-Equity | -0.61 | |||||
Debt-to-EBITDA | -1.18 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -31.41 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 91.3 | |||||
3-Year EBITDA Growth Rate | 33.9 | |||||
3-Year EPS without NRI Growth Rate | 24.8 | |||||
3-Year FCF Growth Rate | 47.7 | |||||
3-Year Book Growth Rate | -135.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.56 | |||||
9-Day RSI | 60.62 | |||||
14-Day RSI | 56.56 | |||||
6-1 Month Momentum % | 63.64 | |||||
12-1 Month Momentum % | 100 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.13 | |||||
Quick Ratio | 0.1 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 117.77 | |||||
Days Sales Outstanding | 28.36 | |||||
Days Payable | 2057.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | -4.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.76 | |||||
Operating Margin % | -292.82 | |||||
Net Margin % | -342.87 | |||||
FCF Margin % | -103.25 | |||||
ROA % | -160.7 | |||||
ROIC % | -103.18 | |||||
ROC (Joel Greenblatt) % | -179.19 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 18.89 | |||||
EV-to-EBIT | -7.01 | |||||
EV-to-EBITDA | -9.18 | |||||
EV-to-Revenue | 20.55 | |||||
EV-to-FCF | -18.94 | |||||
Earnings Yield (Greenblatt) % | -14.26 | |||||
FCF Yield % | -5.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Rapid Dose Therapeutics Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 1.045 | ||
EPS (TTM) (C$) | -0.046 | ||
Beta | -0.96 | ||
Volatility % | 144.55 | ||
14-Day RSI | 56.56 | ||
14-Day ATR (C$) | 0.012807 | ||
20-Day SMA (C$) | 0.164 | ||
12-1 Month Momentum % | 100 | ||
52-Week Range (C$) | 0.09 - 0.275 | ||
Shares Outstanding (Mil) | 104.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rapid Dose Therapeutics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rapid Dose Therapeutics Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Rapid Dose Therapeutics Corp Frequently Asked Questions
What is Rapid Dose Therapeutics Corp(XCNQ:DOSE)'s stock price today?
When is next earnings date of Rapid Dose Therapeutics Corp(XCNQ:DOSE)?
Does Rapid Dose Therapeutics Corp(XCNQ:DOSE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |